BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21152783)

  • 21. New agents, new rashes: an update on skin complications from cancer chemotherapy.
    Patiyil S; Chan SN; Jatoi A
    Curr Oncol Rep; 2006 Jul; 8(4):269-74. PubMed ID: 17254526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
    Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
    Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of skin adverse reactions in oncology.
    Silva D; Gomes A; Ms Lobo J; Almeida V; Almeida IF
    J Oncol Pharm Pract; 2020 Oct; 26(7):1703-1714. PubMed ID: 32635811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.
    Perez EA; Campbell DL; Ryu JK
    Cancer Invest; 1995; 13(6):604-7. PubMed ID: 7583710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucocutaneous side effects of antineoplastic chemotherapy.
    Guillot B; Bessis D; Dereure O
    Expert Opin Drug Saf; 2004 Nov; 3(6):579-87. PubMed ID: 15500416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications.
    Zur E
    Int J Pharm Compd; 2018; 22(6):446-454. PubMed ID: 30384344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iatrogenic skin disease.
    Verbov J
    Br J Clin Pract; 1973 Aug; 27(8):510-4. PubMed ID: 4271486
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adverse chemotherapy effects on skin and mucous membranes].
    Trojan A; Borelli S
    Praxis (Bern 1994); 2002 Jun; 91(24):1078-87. PubMed ID: 12109057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adverse skin reactions induced by BRAF inhibitors: a systematic review].
    Sibaud V; Lamant L; Maisongrosse V; Delord JP
    Ann Dermatol Venereol; 2013; 140(8-9):510-20. PubMed ID: 24034635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts.
    Choi JN
    Clin Dermatol; 2011; 29(6):587-601. PubMed ID: 22014981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin toxicity of anti-cancer therapy.
    Ulrich J; Hartmann JT; Dörr W; Ugurel S
    J Dtsch Dermatol Ges; 2008 Nov; 6(11):959-77. PubMed ID: 18992037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib.
    Beldner M; Jacobson M; Burges GE; Dewaay D; Maize JC; Chaudhary UB
    Oncologist; 2007 Oct; 12(10):1178-82. PubMed ID: 17962611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Side effect of oncological treatment in skin and adnexae].
    Haagen J; Hartmann JT; Schmidt M; Ugurel S; Ulrich J; Dörr W
    MMW Fortschr Med; 2010 Nov; 152(46):34-6. PubMed ID: 21229721
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse cutaneous reactions to chemotherapeutic drugs.
    Haynes D; Ortega-Loayza AG
    Clin Dermatol; 2020; 38(6):712-728. PubMed ID: 33341204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors.
    Lupu I; Voiculescu VM; Bacalbasa N; Prie BE; Cojocaru I; Giurcaneanu C
    J Med Life; 2015; 8 Spec Issue(Spec Issue):57-61. PubMed ID: 26361513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatologic toxicity of chemotherapeutic agents.
    Payne AS; James WD; Weiss RB
    Semin Oncol; 2006 Feb; 33(1):86-97. PubMed ID: 16473647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe cutaneous toxicity during concomitant radiotherapy and cetuximab treatment of head and neck cancer.
    Vano-Galvan S; de las Heras E; Harto A; Jaen P
    Eur J Dermatol; 2008; 18(4):471-2. PubMed ID: 18573734
    [No Abstract]   [Full Text] [Related]  

  • 38. Skin fragility and blistering secondary to imatinib.
    Reddy H; Horne HL; Maung Z
    Clin Exp Dermatol; 2012 Jul; 37(5):572-3. PubMed ID: 22224491
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychiatric medications: adverse cutaneous drug reactions.
    Bliss SA; Warnock JK
    Clin Dermatol; 2013; 31(1):101-9. PubMed ID: 23245981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sunlight and the skin.
    Belisario JC
    Int J Dermatol; 1972; 11(4):200-10. PubMed ID: 4266894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.